G67S (p.Gly67Ser) variant of KRT16 (Keratin, type I cytoskeletal 16)

G67S (p.Gly67Ser) in KRT16 (Keratin, type I cytoskeletal 16) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as benign/likely benign in the context of not provided. The available variant effect predictions contribute to a CATVariant prioritization score of 0.28 / 1. The record also includes population frequency data and structural context.

G67S (p.Gly67Ser) variant details